Featured Research

from universities, journals, and other organizations

Washington, D.C. study shows racial disparities in emergency stroke treatment

Date:
July 1, 2011
Source:
Washington Hospital Center
Summary:
A recent Washington, D.C. citywide study demonstrates racial disparities in the use of clot-busting drugs to treat acute ischemic stroke, the most common type of stroke.

A Washington, D.C. citywide study published online in Stroke: Journal of the American Heart Association demonstrates racial disparities in the use of clot-busting drugs to treat acute ischemic stroke, the most common type of stroke.

Related Articles


According to the study's results, significantly fewer black patients receive the drug tPA than whites because of delays in seeking emergency care and the presence of medical conditions that exclude them from receiving the treatment. On the other hand, racial bias in doctors' treatment decisions do not appear to be a factor.

Amie Hsia, MD, medical director of the Stroke Center at Washington Hospital Center and assistant professor in Georgetown University's Department of Neurology, led the study that looked at 1,044 patients treated for stroke from Feb. 1, 2008 to Jan. 31, 2009 at seven acute-care hospitals in the District of Columbia.

Of the patients studied, 775 (80%) were black, and 198 (20%) were white. Only three percent of the black patients received intravenous tPA, the best available treatment, versus 10 percent of the white patients. Formally known as tissue plasminogen activator, tPA has been demonstrated to improve stroke outcomes by breaking up the clot that is blocking the blood flow to the brain.

In order for tPA to be effective, a patient must be treated within three hours of the onset of symptoms and show disabling deficits such as pronounced weakness or severe speech difficulty. Additionally, patients can be ineligible for tPA if they have had a recent stroke, a history of a brain bleed or blood pressure that's too high to safely administer the treatment.

According to the study, the vast majority of black patients are ineligible for the treatment once they arrive at the hospital in large part because of the delay in seeking treatment and the effects of poorly controlled stroke risk factors such as high blood pressure or a recent stroke that made them unsafe candidates for treatment. For those eligible for tPA, there were no statistical differences in the race of those who received treatment, indicating that race was not a factor in whether doctors administered tPA to eligible patients.

The study falls in line with one published online in the same journal on May 5, 2011, also from Dr. Hsia, which reveals that blacks more often called friends or family first instead of 911 when they experienced stroke symptoms, often leading to a delay in treatment and poor outcomes.

"This finding is, on one hand, reassuring to us as providers because it shows no bias on the part of those treating the patients as the reason for disparities in the administration of tPA," said Dr. Hsia. "However, it also highlights the crucial need for more effective education targeted to our urban black population on the symptoms of stroke and actions they must take in order to get proper treatment right away."

The National Institute of Neurological Disorders and Stroke and the National Center on Minority Health and Health Disparities funded the research.


Story Source:

The above story is based on materials provided by Washington Hospital Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Amie W. Hsia, Dorothy F. Edwards, Lewis B. Morgenstern, Jeffrey J. Wing, Nina C. Brown, Regina Coles, Sarah Loftin, Andrea Wein, Sara S. Koslosky, Sabiha Fatima, Brisa N. Sαnchez, Ali Fokar, M. Chris Gibbons, Nawar Shara, Annapurni Jayam-Trouth, and Chelsea S. Kidwell. Racial Disparities in Tissue Plasminogen Activator Treatment Rate for Stroke: A Population-Based Study. Stroke: Journal of the American Heart Association, 2011; DOI: 10.1161/STROKEAHA.111.613828

Cite This Page:

Washington Hospital Center. "Washington, D.C. study shows racial disparities in emergency stroke treatment." ScienceDaily. ScienceDaily, 1 July 2011. <www.sciencedaily.com/releases/2011/07/110701150445.htm>.
Washington Hospital Center. (2011, July 1). Washington, D.C. study shows racial disparities in emergency stroke treatment. ScienceDaily. Retrieved March 30, 2015 from www.sciencedaily.com/releases/2011/07/110701150445.htm
Washington Hospital Center. "Washington, D.C. study shows racial disparities in emergency stroke treatment." ScienceDaily. www.sciencedaily.com/releases/2011/07/110701150445.htm (accessed March 30, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, March 30, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Soda, Salt and Sugar: The Next Generation of Taxes

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline. Video provided by Washington Post
Powered by NewsLook.com
UnitedHealth Buys Catamaran

UnitedHealth Buys Catamaran

Reuters - Business Video Online (Mar. 30, 2015) — The $12.8 billion merger will combine the U.S.&apos; third and fourth largest pharmacy benefit managers. Analysts say smaller PBMs could also merge. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins